Víctor López

Dr. Víctor López

Universidad San Jorge
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
BSBahare Salehi
Bahare Salehi
CQCristina Quispe
Cristina Quispe
ICImane Chamkhi
Imane Chamkhi
NONasreddine El Omari
Nasreddine El Omari
ABAbdelaali Balahbib
Abdelaali Balahbib
Francisco LesFrancisco Les
Francisco Les
Chalcones are among the leading bioactive flavonoids with a therapeutic potential implicated to an array of bioactivities investigated by a series of preclinical and clinical studies. In this article, different scientific databases were searched to retrieve studies depicting the biological activities of chalcones and their derivatives. This review comprehensively describes preclinical studies on chalcones and their derivatives describing their immense significance as antidiabetic, anticancer, anti-inflammatory, antimicrobial, antioxidant, antiparasitic, psychoactive, and neuroprotective agents. Besides, clinical trials revealed their use in the treatment of chronic venous insufficiency, skin conditions, and cancer. Bioavailability studies on chalcones and derivatives indicate possible hindrance and improvement in relation to its nutraceutical and pharmaceutical applications. Multifaceted and complex underlying mechanisms of chalcone actions demonstrated their ability to modulate a number of cancer cell lines, to inhibit a number of pathological microorganisms and parasites, and to control a number of signaling molecules and cascades related to disease modification. Clinical studies on chalcones revealed general absence of adverse effects besides reducing the clinical signs and symptoms with decent bioavailability. Further studies are needed to elucidate their structure activity, toxicity concerns, cellular basis of mode of action, and interactions with other molecules.

19 May 2017 in Frontiers in Pharmacology
Verified
Journal Article
Open access
Víctor LópezVíctor López
Víctor López
BNBirgitte Nielsen
Birgitte Nielsen
MSMaite Solas
Maite Solas
MRMaria J. Ramírez
Maria J. Ramírez
AJAnna K. Jäger
Anna K. Jäger
Lavender essential oil is traditionally used and approved by the European Medicines Agency as herbal medicine to relieve stress and anxiety. Some animal and clinical studies reveal positive results in models of anxiety and depression although very little research has been done on molecular mechanisms. Our work consisted of evaluating the effects of lavender (Lavandula angustifolia) essential oil on central nervous system well-established targets such as MAO-A, SERT, GABAA and NMDA receptors as well as in vitro models of neurotoxicity. The results showed that lavender essential oil and its main components exert affinity for the glutamate NMDA-receptor in a dose-dependent manner with an IC50 value of 0.04 µl/mL for lavender oil. In addition, lavender and linalool were also able to bind the serotonin transporter whereas they did not show affinity for GABAA-benzodiazepine receptor. In three different models of neurotoxicity, lavender did not enhance the neurotoxic insult and improved viability of SH-SY5Y cells treated with hydrogen peroxide. According to our data, the anxiolytic and antidepressant-like effects attributed to lavender may be due to an antagonism on the NMDA-receptor and inhibition of SERT. This study suggests that lavender essential oil may exert pharmacological properties via modulating the NMDA receptor, the serotonin transporter as well as neurotoxicity induced by hydrogen peroxide.

11 May 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
Javad Sharifi-RadJavad Sharifi-Rad
Javad Sharifi-Rad
ADAbhijit Dey
Abhijit Dey
Niranjan KoiralaNiranjan Koirala
Niranjan Koirala
SSShabnum Shaheen
Shabnum Shaheen
NONasreddine El Omari
Nasreddine El Omari
Constantin CaruntuConstantin Caruntu
Constantin Caruntu
The genusCinnamomumincludes a number of plant species largely used as food, food additives and spices for a long time. Different traditional healing systems have used these plants as herbal remedies to cure diverse ailments. The aim of this comprehensive and updated review is to summarize the biodiversity of the genusCinnamomum, its bioactive compounds, the mechanisms that underlie the pharmacological activities and molecular targets and toxicological safety. All the data in this review have been collected from databases and recent scientific literature including Web of Science, PubMed, ScienceDirect etc. The results showed that the bioactive compounds ofCinnamomumspecies possess antimicrobial, antidiabetic, antioxidant, anti-inflammatory, anticancer and neuroprotective effects. The preclinical (in vitro/in vivo) studies provided the possible molecular mechanisms of these action. As a novelty, recent clinical studies and toxicological data described in this paper support and confirm the pharmacological importance of the genusCinnamomum.In conclusion, the obtained results from preclinical studies and clinical trials, as well as reduced side effects provide insights into future research of new drugs based on extracts and bioactive compounds fromCinnamomumplants.

3 October 2007 in Plant Foods for Human Nutrition
Verified
Journal Article
Closed access
PDF file
Víctor LópezVíctor López
Víctor López
SASilvia Akerreta
Silvia Akerreta
ECEsther Casanova
Esther Casanova
JGJose Maria Garcia-Mina
Jose Maria Garcia-Mina
RCRita Yolanda Cavero
Rita Yolanda Cavero
MCMaría Isabel Calvo
María Isabel Calvo


7 May 2009 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
Víctor LópezVíctor López
Víctor López
SMSara Martín
Sara Martín
MGM. Pilar Gómez-Serranillos
M. Pilar Gómez-Serranillos
MCMaria Emilia Carretero
Maria Emilia Carretero
AJAnna K. Jäger
Anna K. Jäger
MCMaría Isabel Calvo
María Isabel Calvo